Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-039783
Filing Date
2019-07-01
Accepted
2019-07-01 17:35:19
Documents
1
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4195
  Complete submission text file 0001209191-19-039783.txt   5563
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Issuer) CIK: 0001689813 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Business Address
Gentile Kimberly (Reporting) CIK: 0001704186 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38080 | Film No.: 19934424